USD10
BBIO Shares
About BridgeBio PharmaBridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
USD10
BBIO Shares
About BridgeBio PharmaBridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$14.02B
OPEN PRICE
$71.95
LOW (1Y)
$28.33
HIGH (1Y)
$81.33
LOW (24H)
$71.95
HIGH (24H)
$74.63
VOLUME (24H)
$1.23M
45.47%
Price history
Time | Price | Change |
|---|---|---|
Today | $71.95 | |
1 Day | $73.15 | 0.00% |
1 Week | $68.31 | |
1 Month | $65.13 | |
1 Year | $30.67 |
Past performance is not a reliable indicator of future results.
Discover more
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
